Mythic Therapeutics to Present Data from Phase 1 KisMET-01 Study on MYTX-011 at the American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
HCA Healthcare, Inc. (HCA)
Last hca healthcare, inc. earnings: 4/21 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investor.hcahealthcare.com
Company Research
Source: Yahoo! Finance
antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, today announced that it will present initial dose escalation results from its Phase 1 KisMET-01 study evaluating its investigational cMET-targeting ADC, MYTX-011, in patients with previously treated, locally advanced or metastatic non-small cell lung cancer (NSCLC) at the American Society of Clinical Oncology (ASCO) Annual Meeting. "We are pleased to present clinical data showcasing the potential of our lead program, MYTX-011, for patients impacted by non-small cell lung cancer," said Gilles Gallant, BPharm, Ph.D., FOPQ, Chief Development Officer at Mythic Therapeutics. "The initial dose escalation results from our ongoing KisMET-01 trial mark an important milestone in our journey, and we look forward to sharing these results with the scientific community at ASCO." Details of the presentation are as follows: Title: MYTX-011 in patients with previously treated locally advanced or metastatic NSCL
Show less
Read more
Impact Snapshot
Event Time:
HCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCA alerts
High impacting HCA Healthcare, Inc. news events
Weekly update
A roundup of the hottest topics
HCA
News
- Top ten largest hospitals in Tennessee by bed size in 2021 [Yahoo! Finance]Yahoo! Finance
- HCA Healthcare, Inc. (NYSE: HCA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- ChoiceCash reports title loan demand by US Census Region and Division [Yahoo! Finance]Yahoo! Finance
- Woman fatally struck by police truck on South Carolina beach [CBS News]CBS News
- Indiana weighs hospital monopoly as officials elsewhere scrutinize similar deals [USA TODAY]USA TODAY
HCA
Earnings
- 4/26/24 - Beat
HCA
Sec Filings
- 5/20/24 - Form 4
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- HCA's page on the SEC website